argenx NV ADR

argenx NV ADR

Yahoo Finance • 6 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

European equities traded in the US as American depositary receipts were tracking higher late Thursda PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 11 days ago

argenx (ENXTBR:ARGX) Stock Looks Overvalued After Its 202% Five Year Run

argenx has delivered powerful long term gains, and the latest jump on fresh clinical data has put an even brighter spotlight on whether the current share price is adequately supported by its earnings. With the stock now back in focus after... Full story

Yahoo Finance • 12 days ago

Argenx's Vyvgart Sales Growth, Pipeline Progress Support Outlook, Oppenheimer Says

Argenx's (ARGX) Q3 results highlighted continued growth in Vyvgart sales, while its acquisition of F PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 12 days ago

Argenx's Vyvgart Beats Expectations With Focus Shifting to December Data, RBC Says

Argenx's (ARGX) Vyvgart sales beat expectations in Q3, with investors focused on upcoming multifocal PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 13 days ago

Argenx Slumps On Mixed Third Quarter, Surprise Vyvgart Testing Plans

Argenx stock fell early Thursday despite beating sales expectations on a surprise testing requirement for its drug, Vyvgart. Continue Reading... Full story

Yahoo Finance • 14 days ago

Here are the major earnings before the open Thursday

Major earnings expected before the bell on Thursday include: * The Procter & Gamble Company (PG [https://seekingalpha.com/symbol/PG]) * Lockheed Martin Corporation (LMT [https://seekingalpha.com/symbol/LMT]) * Nokia Oyj (NOK [https:... Full story

Yahoo Finance • 15 days ago

RBC Capital names top healthcare stocks as sector upgraded to overweight

Investing.com -- RBC Capital has upgraded the Healthcare sector to Overweight from Market Weight, identifying 11 high-conviction stock ideas across therapeutics and non-therapeutics segments. The upgrade is supported by improving flows, po... Full story

Yahoo Finance • 15 days ago

European Equities Traded in the US as American Depositary Receipts Advance in Tuesday Trading

European equities traded in the US as American depositary receipts were tracking higher late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 19 days ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

European equities traded in the US as American depositary receipts were tracking higher late Friday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 20 days ago

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

European equities traded in the US as American depositary receipts were sharply higher late Thursday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 21 days ago

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were marginally lower late Wednes PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

argenx (ENXTBR:ARGX) Gets Mixed Trial News, Is It Still Overvalued?

Argenx (ENXTBR:ARGX) is back in focus after twin clinical updates. The company reported positive Phase 2 data for FB102 in celiac disease while deciding to halt its Phase 3 UNITY trial in Sjögren's disease. Over the past month argenx's sh... Full story

Yahoo Finance • 27 days ago

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Thursday afternoon, with the NYSE Healthcare Index shedding 0.6% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 27 days ago

Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's

Argenx unexpectedly scrapped a study of its drug, Vyvgart, in patients with Sjogren's disease on Thursday. The stock plummeted in response. Continue Reading... Full story

Yahoo Finance • 27 days ago

Halozyme Therapeutics (HALO) Expands Argenx Deal, Is It Still 27% Below Fair Value?

Halozyme's argenx expansion puts ENHANZE back in focus Halozyme Therapeutics (HALO) extended its ENHANZE collaboration with argenx to cover two more exclusive targets, taking the total to eight and adding fresh attention to the stock's pa... Full story

Yahoo Finance • last month

Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium

Ginkgo generates antibody data at scale and trains models for drug manufacturability and developability. Apheris' federated infrastructure enables participating pharmaceutical companies to use those models and further fine-tune them on the... Full story

Yahoo Finance • last month

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

argenx SE New data show deepening improvement in ocular MG and sustained one-year efficacy in anti-AChR antibody-negative MG – broadening VYVGART's potential to treat all MG patients Real-world evidence from more than 1,100 U.S. MG patien... Full story

Yahoo Finance • last month

European Equities Traded in the US as American Depositary Receipts Edge Lower in Thursday Trading

European equities traded in the US as American depositary receipts were tracking slightly lower Thur PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

argenx (ENXTBR:ARGX) Shares Moved, So What Is Drawing Attention Now?

argenx (ENXTBR:ARGX) drew fresh attention after its Extraordinary General Meeting confirmed Thomas M. Brakel and Khurem Farooq as new non-executive directors, prompting investors to reassess how board composition might influence longer ter... Full story

Yahoo Finance • last month

These ‘Moonshot’ Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Morgan Stanley highlights high-risk, high-reward biotech stocks poised for massive upside following key upcoming clinical readouts. Continue Reading... Full story